Reuters logo
BRIEF-Karo Pharma Q3 EBITDA up at SEK ‍34.0​ mln
November 2, 2017 / 7:12 AM / a month ago

BRIEF-Karo Pharma Q3 EBITDA up at SEK ‍34.0​ mln

Nov 2 (Reuters) - KARO PHARMA AB:

* Q3 NET SALES SEK ‍137.1​ MILLION VERSUS SEK 85.2 MILLION YEAR AGO

* Q3 EBITDA SEK ‍34.0​ MILLION VERSUS SEK 10.2 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below